Trial Profile
Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2019
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Angina pectoris; Myocardial infarction
- Focus First in man; Pharmacodynamics
- 01 Jul 2018 Primary endpoint has not been met. (The percentage of uncovered struts on 3-month OCT), as reported in an article published in the Yonsei Medical Journal
- 01 Jul 2018 Status changed from recruiting to discontinued, as reported in an article published in the Yonsei Medical Journal
- 01 Jul 2018 Results published in the Yonsei Medical Journal